A carregar...
Trends in the Development and Approval of Monoclonal Antibodies for Viral Infections
Monoclonal antibodies (mAbs) developed for either the prevention or treatment of viral diseases represent a small, but valuable, class of products. Since 1985, commercial firms have initiated clinical studies involving a total of 28 mAbs. To date, one product (palivizumab) has been approved and eigh...
Na minha lista:
| Publicado no: | BioDrugs |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer International Publishing
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7100544/ https://ncbi.nlm.nih.gov/pubmed/17263584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2165/00063030-200721010-00001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|